184 related articles for article (PubMed ID: 31486033)
21. Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer.
Rahman MM; van Oosterom F; Enow JA; Hossain M; Gutierrez-Jensen AD; Cashen M; Everts A; Lowe K; Kilbourne J; Daggett-Vondras J; Karr TL; McFadden G
Cancer Res Commun; 2023 Jun; 3(6):952-968. PubMed ID: 37377603
[TBL] [Abstract][Full Text] [Related]
22. Poxvirus oncolytic virotherapy.
Torres-Domínguez LE; McFadden G
Expert Opin Biol Ther; 2019 Jun; 19(6):561-573. PubMed ID: 30919708
[TBL] [Abstract][Full Text] [Related]
23. RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.
Rahman MM; Gutierrez-Jensen AD; Glenn HL; Abrantes M; Moussatche N; McFadden G
J Virol; 2021 Jun; 95(14):e0015121. PubMed ID: 33952639
[TBL] [Abstract][Full Text] [Related]
24. Genetic Variability of Myxoma Virus Genomes.
Braun C; Thürmer A; Daniel R; Schultz AK; Bulla I; Schirrmeier H; Mayer D; Neubert A; Czerny CP
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903800
[TBL] [Abstract][Full Text] [Related]
25. Identification and Characterisation of a Myxoma Virus Detected in the Italian Hare (
Rossini E; Bazzucchi M; Trocchi V; Merzoni F; Bertasio C; Knauf S; Lavazza A; Cavadini P
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543802
[TBL] [Abstract][Full Text] [Related]
26. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
[TBL] [Abstract][Full Text] [Related]
27. Myxoma virus: propagation, purification, quantification, and storage.
Smallwood SE; Rahman MM; Smith DW; McFadden G
Curr Protoc Microbiol; 2010 May; Chapter 14():Unit 14A.1. PubMed ID: 20440681
[TBL] [Abstract][Full Text] [Related]
28. Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor.
Lilly CL; Villa NY; Lemos de Matos A; Ali HM; Dhillon JS; Hofland T; Rahman MM; Chan W; Bogen B; Cogle C; McFadden G
Mol Ther Oncolytics; 2017 Mar; 4():31-40. PubMed ID: 28345022
[TBL] [Abstract][Full Text] [Related]
29. Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.
Wennier ST; Liu J; Li S; Rahman MM; Mona M; McFadden G
Mol Ther; 2012 Apr; 20(4):759-68. PubMed ID: 22233582
[TBL] [Abstract][Full Text] [Related]
30. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.
Stanford MM; McFadden G
Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
Kellish P; Shabashvili D; Rahman MM; Nawab A; Guijarro MV; Zhang M; Cao C; Moussatche N; Boyle T; Antonia S; Reinhard M; Hartzell C; Jantz M; Mehta HJ; McFadden G; Kaye FJ; Zajac-Kaye M
J Clin Invest; 2019 Apr; 129(6):2279-2292. PubMed ID: 31033480
[TBL] [Abstract][Full Text] [Related]
32. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
[TBL] [Abstract][Full Text] [Related]
33. Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.
Irwin CR; Favis NA; Agopsowicz KC; Hitt MM; Evans DH
PLoS One; 2013; 8(12):e84134. PubMed ID: 24391902
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity.
Garofalo M; Iovine B; Kuryk L; Capasso C; Hirvinen M; Vitale A; Yliperttula M; Bevilacqua MA; Cerullo V
Mol Cancer Ther; 2016 Apr; 15(4):651-60. PubMed ID: 26861248
[TBL] [Abstract][Full Text] [Related]
35. Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.
Rahman MM; Bagdassarian E; Ali MAM; McFadden G
Sci Rep; 2017 Nov; 7(1):15710. PubMed ID: 29146961
[TBL] [Abstract][Full Text] [Related]
36. Autologous Transplantation Using Donor Leukocytes Loaded
Villa NY; Rahman MM; Mamola J; D'Isabella J; Goras E; Kilbourne J; Lowe K; Daggett-Vondras J; Torres L; Christie J; Appel N; Cox AL; Kim JB; McFadden G
Mol Ther Oncolytics; 2020 Sep; 18():171-188. PubMed ID: 32695875
[TBL] [Abstract][Full Text] [Related]
37. Myxoma and vaccinia viruses bind differentially to human leukocytes.
Chan WM; Bartee EC; Moreb JS; Dower K; Connor JH; McFadden G
J Virol; 2013 Apr; 87(8):4445-60. PubMed ID: 23388707
[TBL] [Abstract][Full Text] [Related]
38. Spatiotemporal monitoring of myxomatosis in European wild rabbit (Oryctolagus cuniculus) in Spanish Mediterranean ecosystems.
Camacho-Sillero L; Cardoso B; Beato-Benítez A; Gómez-Guillamón F; Díaz-Cao JM; Jiménez-Martín D; Caballero-Gómez J; Castro-Scholten S; Cano-Terriza D; García-Bocanegra I
Transbound Emerg Dis; 2022 Nov; 69(6):3494-3505. PubMed ID: 36150087
[TBL] [Abstract][Full Text] [Related]
39. Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.
Zemp FJ; McKenzie BA; Lun X; Reilly KM; McFadden G; Yong VW; Forsyth PA
Cancer Res; 2014 Dec; 74(24):7260-73. PubMed ID: 25336188
[TBL] [Abstract][Full Text] [Related]
40. Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.
Kerr PJ; Liu J; Cattadori I; Ghedin E; Read AF; Holmes EC
Viruses; 2015 Mar; 7(3):1020-61. PubMed ID: 25757062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
